SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition

Thyroid cancer (TC) is one of the most common malignancies involving the head and neck, and its incidences are increasing every year. Small G protein signaling modulators 2 (SGSM2) belongs to a newly identified protein group that contributes to numerous cancer progression. However, its role in TC re...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xi, Chen, Dong, Zhu, Lizhang, Jia, Hao, Cai, Jiaxuan, Li, Peng, Han, Bin, Wang, Donglai, Li, Hongtao, Fan, Jiaqian, Gu, Mengwei, Zhou, Yaqi, Guan, Haixia, Wei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907342/
https://www.ncbi.nlm.nih.gov/pubmed/35264562
http://dx.doi.org/10.1038/s41419-022-04598-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907342/
https://www.ncbi.nlm.nih.gov/pubmed/35264562
http://dx.doi.org/10.1038/s41419-022-04598-y

Ejemplares similares